Literature DB >> 12479721

Otolaryngologic surgery in children with von Willebrand disease.

Victor Jiménez-Yuste1, María P Prim, Juan I De Diego, Ana Villar, Manuel Quintana, Iñaki Rabanal, Noelia Sastre, Fernando Hernández-Navarro.   

Abstract

OBJECTIVE: To assess the efficacy, safety, and complications of otolaryngologic surgery in children with von Willebrand disease (vWD) undergoing surgery.
DESIGN: A prospective, controlled study of 41 children with vWD who underwent surgery between June 1, 1999, and January 31, 2001.
SETTING: A tertiary care, university-based children's hospital.
INTERVENTIONS: All children had a preoperative diagnosis of vWD. The patients were treated with either a protocol that includes the use of desmopressin acetate and tranexamic acid (37 children) or factor VIII concentrate in children with a positive history of seizures (4 children). MAIN OUTCOME MEASURES: Immediate and delayed postoperative bleeding, hyponatremia, seizures, and urine output.
RESULTS: Two adenotonsillectomy patients (5%) had an immediate postoperative hemorrhage. Delayed postoperative bleeding was not detected in our patients. Severe hyponatremia occurred in 2 patients (1 of them with clinical manifestations).
CONCLUSIONS: Our management of children with vWD was efficacious in otolaryngologic surgery. One child had important adverse effects with the use of desmopressin (seizure). Thus, the use of desmopressin should be weighed and closely monitored.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479721     DOI: 10.1001/archotol.128.12.1365

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

Review 1.  Von Willebrand disease in the United States: a perspective from Wisconsin.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Daniel B Bellissimo; Sandra L Haberichter; Robert R Montgomery
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

2.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

Authors:  Nathan T Connell; Veronica H Flood; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Alice Arapshian; Susie Couper; Jean M Grow; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Sarah H O'Brien; Margareth C Ozelo; Alberto Tosetto; Angela C Weyand; Paula D James; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

Review 3.  The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients.

Authors:  Johnny Cai; Jessica Ribkoff; Sven Olson; Vikram Raghunathan; Hanny Al-Samkari; Thomas G DeLoughery; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2019-12-16       Impact factor: 2.997

4.  [Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count].

Authors:  K Scheckenbach; H Bier; T K Hoffmann; J P Windfuhr; M Bas; H-J Laws; C Plettenberg; M Wagenmann
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.